The trial also revealed statistically significant and clinically meaningful gains in key patient-reported outcomes
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Currently approved for patients eight and older, Tzield could now be used to delay the onset of stage 3 type 1 diabetes (T1D) in children diagnosed with stage 2 T1D
Heart failure affects an estimated 64.3 million people worldwide
The study will run across 18 sites and enroll roughly 200 patients over 24 months
The surgical team used LD Flap Reconstruction, a specialised technique that rebuilt elbow strength and movement
The resubmission of BLA for MOLBREEVI names Fujifilm as the drug substance manufacturer
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
TactiFlex, the world’s first catheter with a flexible tip and contact?force sensing, allows doctors to deliver energy precisely and safely.
Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease
Subscribe To Our Newsletter & Stay Updated
